Bladder Cancer

Men treated with radiotherapy and prostatectomy for prostate cancer exhibit significantly higher risk for numerous urinary and sexual complications compared with the general population, according to results of a cohort study.

Antibiotics remain the most common way to treat urinary tract infections, yet many women remain untreated because the condition is often overlooked or they do not receive appropriate testing and care.

Higher omega-3 and omega-6 fatty acid levels may help reduce cancer risk, according to study findings.

Gilead Sciences announced its intention to voluntarily withdraw the accelerated approval for sacituzumab govitecan-hziv for treatment of certain patients with advanced bladder cancer.

A novel drug delivery construct may protect individuals against cisplatin-induced ototoxicity and associated hearing loss.

People with MS had an increased risk for bladder, brain and cervical cancers compared with people without MS, according to a new study in Neurology, the medical journal of the American Academy of Neurology.

Extended lymphadenectomy offered no survival benefit for patients with localized muscle-invasive bladder cancer compared with bilateral standard lymphadenectomy for patients undergoing radical cystectomy, according to study findings.

Use of durvalumab before and after radical cystectomy improved outcomes for patients with muscle-invasive bladder cancer, according to results of the randomized phase 3 NIAGARA trial.